W921
Pill imprint W921 has been identified as Cefuroxime axetil 250 mg.
Cefuroxime is used in the treatment of urinary tract infection; bacterial infection; bladder infection; bronchitis; sinusitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefuroxime 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefuroxime axetil Images
- Imprint:
-
W921
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Wockhardt USA
- National Drug Code (NDC):
- 64679-0921
Advertisement
More Cefuroxime Axetil resources
- Cefuroxime (Wolters Kluwer)
- Cefuroxime Suspension (Wolters Kluwer)
- Cefuroxime Tablets (Wolters Kluwer)
- cefuroxime (Cerner Multum)
- cefuroxime (Micromedex) - Includes Dosage Information
- cefuroxime Injection, Intravenous (Micromedex) - Includes Dosage Information
- Cefuroxime Axetil (AHFS DI)
- Cefuroxime Sodium (AHFS DI)
- Cefuroxime Axetil (FDA)
- Cefuroxime Dextrose (FDA)
- Cefuroxime Injection (FDA)
- Cefuroxime (Wolters Kluwer)
Cefuroxime Axetil is associated with the treatment of:
- Bacterial Infection
- Bladder Infection
- Bone infection
- Bronchitis
- Epiglottitis
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Impetigo
- Joint Infection
- Kidney Infections
- Lyme Disease
- Meningitis
- Otitis Media
- Peritonitis
- Pneumonia
- Sepsis
- Sinusitis
- Skin and Structure Infection
- Skin Infection
- Strep Throat
- Surgical Prophylaxis
- Tonsillitis/Pharyngitis
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Search Again
